Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 163-168

  McCallum, Roland W ^a   Parameswaran, Venkat ^a   Burgess, John R ^a,b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; BRONCHUS CARCINOID; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GASTRIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS DISEASE; PANCREAS SURGERY; PARATHYROIDECTOMY; PATIENT ASSESSMENT; PEDIGREE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EPIDEMIOLOGIC METHODS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PEDIGREE; PHENOTYPE; RISK FACTORS;

EID: 33746084174     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02563.x     Document Type: Article

References (31)

1. Marx, S., Spiegel, A.M., Doppman, J.L., Collins, F.S. & Liotta, L.A. (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Annals of Internal Medicine, 129, 484-494.
2. Skogseid, B., Rastad, J. & Oberg, K. (1994) Multiple endocrine neoplasia type 1: clinical features and screening. Endocrinology and Metabolism Clinics of North America, 1, 1-18.
3. Ki Wong, F., Burgess, J., Nordenskjold, M., Larsson, C. & Tean Teh, B. (2000) Multiple endocrine neoplasia type 1. Seminars in Cancer Biology, 10, 299-312.
4. Geerdink, E.A.M., Van der Luijt, R.B. & Lips, C.J.M. (2003) Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? European Journal of Endocrinology, 149, 577-582.
5. Doherty, G.M., Olson, J.A., Frisella, M.M., Lairmore, T.C., Wells, S.A. Jr & Norton, J.A. (1998) Lethality of multiple endocrine neoplasia type 1. World Journal of Surgery, 22, 581-587.
6. Wilkinson, S., Teh, B.T., Davey, K.R., McArdle, J.P., Young, M. & Shepherd, J.J. (1993) Cause of death in multiple endocrine neoplasia type 1. Archives of Surgery, 128, 683-690.
7. Dean, P.G., van Heerden, J.A., Farley, D.R., Thompson, G.B., Grant, C.S., Harmen, W.S. & Ilstrup, D.M. (2000) Are patients with multiple endocrine neoplasia type 1 prone to premature death? World Journal of Surgery, 24, 1437-1441.
8. Nilsson, I.L., Wadsten, C., Brandt, L., Rastad, J. & Ekbom, A. (2004) Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery, 136, 981-987.
9. Wagner, A.M., Martin-Campos, J.M., Mayoral, C., de Leiva, A. & Blanco-Vaca, F. (2005) Patients with MEN-1 are more insulin-resistant than their non-affected relatives. European Journal of Internal Medicine, 16, 507-509.
10. Meigs, J.B., Nathan, D.M., Wilson, P.W., Cupples, L.A. & Singer, D.E. (1998) Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Annals of Internal Medicine, 128, 524-533.
11. Burnett, M.S., Devaney, J.M., Adenika, R.J., Lindsay, R. & Howard, B.V. (2005) Cross Sectional Associations of Resistin, Coronary Heart Disease and Insulin Resistance. Journal of Clinical Endocrinology and Metabolism Epub doi:10.1210/jc.2005-1653.
12. Ritchie, S.A., Ewart, M.A., Perry, C.G., Connell, J.M. & Salt, I.P. (2004) The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clinical Science, 107, 519-532.
13. Cryer, P.E. & Polonsky, K.S. (1998) Glucose homeostasis and hypoglycaemia. In: J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen eds. Williams Textbook of Endocrinology, 9th edn. W.B. Saunders, Philadelphia, 942-946.
14. Burgess, J.R., Greenaway, T.M., Parameswaran, V., Challis, D., David, R. & Shepherd, J.J. (1998) Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis. Cancer, 83, 428-434.
15. Kloppel, G., Willemer, S., Stamm, B., Hacki, W.H. & Heitz, P.U. (1986) Pancreatic lesions and hormonal profile of pancreatic tumours in multiple endocrine neoplasia type 1. Cancer, 57, 1824-1832.
16. Burgess, J.R., Greenaway, T.M. & Shepherd, J.J. (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. Journal of Internal Medicine, 243, 465-470.
17. Shepherd, J.J. (1991) The natural history of multiple endocrine neoplasia type 1: highly uncommon or highly unrecognised? Archives of Surgery, 126, 935-952.
18. Burgess, J.R., Nord, B., David, R., Greenaway, T.M., Parameswaran, V., Larsson, C., Shepherd, J.J. & Teh, B.T. (2000) Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1. Clinical Endocrinology, 53, 205-211.
19. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., deCourten, M.P., Cameron, A.J., Sicree, R.A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., Atkins, R. & Shaw, J.E. (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care, 25, 829-834.
20. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
21. Welborn, T., Knuiman, M., Bartholomew, H. & Whittall, D. (1995) 1989-90 National Health Survey: prevalence of self-reported diabetes in Australia. Medical Journal of Australia, 163, 129-132.
22. Kobberling, J. & Tillil, H. (1982) Empirical risk figures for first degree relatives of non-insulin dependent diabetics. In: J. Kobberling, R. Tattersall eds. The Genetics of Diabetes Mellitus. Proceedings of the Seronon Symposia, Vol. 47. Academic Press, London, 201-209.
23. Gallo, A., Cuozzo, C., Esposito, I., Maggiolini, M., Bonofiglio, D., Vivacqua, A., Garramone, M., Weiss, C., Bohmann, D. & Musti, A.M. (2002) Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene, 21, 6434-6445.
24. Burgess, J.R., Shepherd, J.J., Parameswaran, V., Hoffman, L. & Greenaway, T.M. (1996) Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. Journal of Clinical Endocrinology and Metabolism, 81, 2642-2646.
25. Chiu, K.C., Chuang, L.M., Lee, N.P., Ryu, J.M., McGullam, J.L., Tsai, G.P. & Saad, M.F. (2000) Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism, 49, 1501-1505.
26. Silverberg, S.J. (2002) Non-classical target organs in primary hyperparathyroidism. Journal of Bone and Mineral Research, 17, N117-N125.
27. Furuto-Kato, S., Shimatsu, A., Kuzuya, H., Matsuda, K., Nakao, K. & Imura, H. (1994) Insulin sensitivity and glycaemic control before and after parathyroidectomy in a diabetic patients with familial multiple endocrine neoplasia type 1. Endocrine Journal, 41, 731-735.
28. Burgess, J.R., Harle, R.A., Tucker, P., Parameswaran, V., Davies, P., Greenaway, T.M. & Shepherd, J.J. (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Archives of Surgery, 131, 699-702.
29. Skogseid, B., Rastad, J., Gobl, A., Larsson, C., Backlin, K., Juhlin, C., Akerstrom, G. & Oberg, K. (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery, 118, 1077-1082.
30. Granberg, D., Stridsberg, M., Seensalu, R., Eriksson, B., Lundqvist, G., Oberg, K. & Skogseid, B. (1999) Plasma chromogranin A in patients with multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism, 84, 2712-2717.
31. Darling, T.N., Skarulis, M.C., Steinberg, S.M., Marx, S.J., Spiegel, A.M. & Turner, M. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Archives of Dermatology, 133, 853-857.